BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Vitae Pharma To Host Analyst And Investor Briefing

  October 20, 2015

   · 

  1 min read
• Biotech Beach

  Avita Medical Nabs AUD$10M Financing for ReCell Rollout

  October 20, 2015

   · 

  4 min read
• Biotech Bay

  Nasdaq Gives Cesca Therapeutics A New Deadline

  October 20, 2015

   · 

  1 min read
• Business

  Bay Area’s ForSight Vision5 Grabs Another $8 Million

  October 20, 2015

   · 

  1 min read
• Deals

  Advanced Inhalation Therapies Reveals Finances Ahead of $36 Million IPO

  October 20, 2015

   · 

  1 min read
• Drug Development

  CytoDyn Files An IND And Full Protocol For Phase II Study In GvHD

  October 20, 2015

   · 

  8 min read
• Drug Development

  Foamix Pharmaceuticals, Ltd. Announces Enrollment Of First Patient In Phase II Clinical Trial Of FMX103 In Papulopustular Rosacea

  October 20, 2015

   · 

  2 min read
• Business

  Kite Pharma Announces Exclusive License With The NIH For T Cell Receptor (TCR)-Based Products To Treat Tumors Expressing MAGE

  October 20, 2015

   · 

  3 min read
• Drug Development

  Immunomedics, Inc. Reports Durable Responses In Patients With Advanced Solid Cancers After Therapy With Sacituzumab Govitecan

  October 20, 2015

   · 

  10 min read
• Biotech Beach

  Amphastar Pharmaceuticals, Inc. Launches Amphadase

  October 20, 2015

   · 

  3 min read